Drugs Details

Drugs Info of Cantil
Drugs Details
  • Drugs Type  : Multum
  • Date : 28th Feb 2015 12:44 am
  • Brand Name : Cantil
  • Generic Name : mepenzolate (Pronunciation: me PEN zoe late)
Descriptions

CANTIL tablets for oral administration contain 25 mg mepenzolate bromide USP. The anticholinergic agent mepenzolate bromide USP chemically is 3-[(hydroxydiphenylacetyl)oxy]-1,1-dimethylpiperidinium bromide and has the following structure:

 

CANTIL (mepenzolate bromide) structural formula illustration

 

Mepenzolate bromide occurs as a white or light cream-colored powder, which is freely soluble in methanol, slightly soluble in water and chloroform, and practically insoluble in ether. Each yellow tablet contains 25 mg mepenzolate bromide USP. This tablet also contains inactive ingredients: confectioners' sugar, corn starch, corn syrup solids, FD&C Yellow No. 5 (tartrazine), (see PRECAUTIONS, General), lactose, magnesium stearate and microcrystalline cellulose.

 

What are the possible side effects of mepenzolate (Cantil)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using mepenzolate and call your doctor at once if you have any of these serious side effects:

  • urinating less than usual or not at all;
  • confusion, hallucinations;
  • unusual thoughts or behavior; or
  • fast, pounding, or uneven heartbeats.

Less serious side effects may include:

  • drowsiness, dizziness, headache;
  • blurred vision;
  • memory...

Read All Potential Side Effects and See Pictures of Cantil »

What are the precautions when taking mepenzolate bromide (Cantil)?

Before taking mepenzolate, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: glaucoma, myasthenia gravis, movement/blockage disorders of the stomach/bowels (e.g., paralytic ileus, pyloroduodenal stenosis, achalasia, intestinal atony), difficulty urinating (e.g., prostatic hypertrophy), a certain bowel disorder (toxic megacolon).

Before using this medication, tell your doctor or pharmacist your medical history, especially of: liver disease,...

Read All Potential Precautions of Cantil »

 

This monograph has been modified to include the generic and brand name in many instances.

Indications

CANTIL (mepenzolate bromide) is indicated for use as adjunctive therapy in the treatment of peptic ulcer. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.

Dosage Administration

The usual adult dose is 1 or 2 tablets (25 or 50 mg) 4 times a day preferably with meals and at bedtime. Begin with the lower dosage when possible and adjust subsequently according to the patient's response.

Safety and efficacy in pediatric patients have not been established.

In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy. (See PRECAUTIONS, Geriatric Use.)

How Supplied

25 mg mepenzolate bromide, compressed yellow tablets debossed MERRELL 37.

NDC 0068-0037-01: bottles of 100

Keep tightly closed. Store at room temperature, preferably below 86°F. Protect from excessive heat. Dispense in tight containers with child-resistant closure.

Rev. February 2006. Manufactured for: sanofi-aventis U.S. LLC Bridgewater, NJ 08807.

This monograph has been modified to include the generic and brand name in many instances.

Side Effects

Precise frequency data from controlled clinical studies with CANTIL (mepenzolate bromide) are not available.

Gastrointestinal System: vomiting, nausea, constipation, loss of taste, bloated feeling, dry mouth

Central Nervous System: mental confusion, dizziness, weakness, drowsiness, headache, nervousness

Ophthalmologic: increased ocular tension, cycloplegia, blurred vision,dilation of the pupil

Dermatologic-Hypersensitivity: anaphylaxis, urticaria

Cardiovascular: tachycardia, palpitations

Genitourinary: urinary retention, urinary hesitancy

Miscellaneous: decreased sweating, drowsiness, insomnia, impotence, suppression of lactation

Drug Abuse And Dependence

Tolerance, abuse, or dependence has not been reported with CANTIL (mepenzolate bromide) .

Read the Cantil (mepenzolate bromide) Side Effects Center for a complete guide to possible side effects

Learn More »
 
 
 

Interactions

The following agents may increase certain actions or side effects ofanticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines),benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.

Anticholinergics antagonize the effects of antiglaucoma agents. Anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids. (See CONTRAINDICATIONS.)

Anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin; increased serumdigoxin concentrations may result. Anticholinergic drugs may antagonize the effects of drugs that alter gastrointestinal motility, such as metoclopramide. Because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided.

The inhibiting effects of anticholinergic drugs on gastric hydrochloric acid secretion are antagonized by agents used to treat achlorhydria and those used to test gastric secretion.

Read the Cantil Drug Interactions Center for a complete guide to possible interactions

Learn More »
 

This monograph has been modified to include the generic and brand name in many instances.

Warnings

In the presence of high environmental temperature, heat prostration (feverand heat stroke due to decreased sweating) can occur with use of CANTIL (mepenzolate bromide) .

Diarrhea may be an early symptom of incomplete intestinal obstructionespecially in patients with ileostomy or colostomy. In this instance, treatment with this drug would be inappropriate and possibly harmful.

CANTIL (mepenzolate bromide) may produce drowsiness or blurred vision. The patient should be cautioned regarding activities requiring mental alertness such as operating a motor vehicle or other machinery or performing hazardous work while taking this drug.

With overdosage, a curare-like action may occur i.e., neuromuscularblockage leading to muscular weakness and possible paralysis.

It should be noted that the use of anticholinergic drugs in the treatment ofgastric ulcer may produce a delay in gastric emptying time and may complicate such therapy (antral stasis). Psychosis has been reported in sensitive individuals given anticholinergic drugs. CNS signs and symptoms include confusion, disorientation, short-term memory loss, hallucinations,dysarthria, ataxia, coma, euphoria, decreased anxiety, fatigue, insomnia, agitation and mannerisms and inappropriate affect. These CNS signs and symptoms usually resolve within 12 to 24 hours after discontinuation of the medication.

Precautions

General

Use CANTIL (mepenzolate bromide) with caution in the elderly (seePRECAUTIONS, Geriatric Use) and in all patients with:

  1. Autonomic neuropathy
  2. Hepatic or renal disease
  3. Ulcerative colitis. Large doses may suppress intestinal motility to the point of producing a paralytic ileus and for this reason precipitate or aggravate "toxic megacolon," a serious complication of the disease.
  4. Hiatal hernia associated with reflux esophagitis, since anticholinergic drugs may aggravate this condition.
  5. Coronary heart disease
  6. Congestive heart failure
  7. Cardiac arrhythmias
  8. Tachycardia
  9. Hypertension
  10. Prostatic hypertrophy
  11. Hyperthyroidism

Investigate any tachycardia before giving anticholinergic (atropine-like) drugs since they may increase the heart rate.

This product contains FD&C Yellow No. 5 (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible individuals. Although the overall incidence of FD&C Yellow No. 5 (tartrazine)sensitivity in the general population is low, it is frequently seen in patients who also have aspirin sensitivity.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No data are available on long-term potential for carcinogenicity, mutagenicity, or impairment of fertility in animals or humans.

Pregnancy

Teratogenic Effects.Pregnancy Category B.Reproduction studies have been performed in rats and rabbits at doses up to 30 times the human dose (based on 50 kg weight) and have shown no evidence of impaired fertility or harm to the animal fetus. There are, however, no adequate and well-controlled studies with CANTIL (mepenzolate bromide) in pregnant women. Because animal reproduction studies are not always predictive of human response, CANTIL (mepenzolate bromide) should be used during pregnancy only if clearly needed.

Nonteratogenic Effects. No data are available on nonteratogenic effects in the fetus or newborn infant.

Nursing Mothers

It is not known whether CANTIL (mepenzolate bromide) is secreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when CANTIL (mepenzolate bromide) is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Studies in newborn animals (rats) show that younger animals are more sensitive to the toxic effects of CANTIL (mepenzolate bromide) than are older animals.

Geriatric Use

Clinical studies of CANTIL (mepenzolate bromide) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range (See DOSAGE AND ADMINISTRATION), reflecting the greater frequency of decreased hepatic, renal or cardiac function (see PRECAUTIONS, General), and of concomitant disease or other drug therapy. (See PRECAUTIONS: DRUG INTERACTIONS.)

CANTIL (mepenzolate bromide) is contraindicated in intestinal atony of the elderly. (See CONTRAINDICATIONS.) CANTIL (mepenzolate bromide) should be used with caution in the elderly. (See PRECAUTIONS, General.)

This monograph has been modified to include the generic and brand name in many instances.

OverDose

Signs and Symptoms

The signs and symptoms of overdosage are headache; nausea; vomiting;blurred vision; dilated pupils; hot, dry skin; dizziness; dryness of the mouth; difficulty in swallowing; and CNS stimulation. A curare-like action may occur (i.e., neuromuscular blockade leading to muscular weakness and possibleparalysis).

Oral LD50

The oral LD50 is greater than 750 mg/kg in mice and greater than 1000 mg/kg in rats. Maximum Human Dose Recorded

The maximum human dose recorded is 375 to 500 mg in a 4-year-old child (no adverse effects reported) and 500 to 750 mg in a 30-year-old adult (resulted in death).

Dialysis

It is not known if the drug is dialyzable.

Treatment

Treatment should consist of gastric lavage, emetics, and activated charcoal. Sedatives (e.g., short-acting barbiturates, benzodiazepines) may be used for management of overt signs of excitement. If indicated, an appropriateparenteral cholinergic agent may be used as an antidote.

ContrainDications

  1. Glaucoma
  2. Obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy)
  3. Obstructive disease of the gastrointestinal tract (for example, pyloroduodenal stenosis, achalasia)
  4. Paralytic ileus
  5. Intestinal atony of the elderly or debilitated patient (See PRECAUTIONS, Geriatric Use)
  6. Unstable cardiovascular status in acute gastrointestinal hemorrhage
  7. Toxic megacolon complicating ulcerative colitis
  8. Myasthenia gravis
  9. Allergic or idiosyncratic reactions to CANTIL (mepenzolate bromide) or related compounds

This monograph has been modified to include the generic and brand name in many instances.

Clinical Pharamacology

CANTIL (mepenzolate bromide) diminishes gastric acid and pepsin secretion. CANTIL (mepenzolate bromide) also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. Radiotracer studies in which CANTIL (mepenzolate bromide) -14C was used in animals and humans indicate theabsorption following oral administration, as with other quaternary ammonium compounds, is low. Between 3 and 22% of an orally administered dose is excreted in the urine over a 5-day period, with the majority of the radioactivity appearing on Day 1. The remainder appears in the next 5 days in the feces and presumably has not been absorbed.

This monograph has been modified to include the generic and brand name in many instances.

Patient Information

CANTIL (mepenzolate bromide) may produce drowsiness or blurred vision. The patient should be cautioned regarding activities requiring mental alertness, such as operating a motor vehicle or other machinery or performing hazardous work while taking this drug.

This monograph has been modified to include the generic and brand name in many instances.

Consumer Overview Uses

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

 

MEPENZOLATE- ORAL

 

(me-PEN-zoe-late)

 

COMMON BRAND NAME(S): Cantil

 

USES: Mepenzolate is used with other medications to treat peptic ulcers. It works by decreasing the release of acid in the stomach.

 

OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.

This drug may also be used with other medications to treat certain bowel disorders (e.g., irritable bowel syndrome). It works by decreasing the movement of the stomach/intestines.

 

HOW TO USE: Take this medication by mouth, usually 4 times daily (with meals and at bedtime) or as directed by your doctor.

Dosage is based on your medical condition and response to therapy.

Use this medication regularly to get the most benefit from it. To help you remember, take it at the same times each day.

Antacids may decrease the absorption of this medication. Take mepenzolate at least 1 hour before taking antacids.

Inform your doctor if your condition persists or worsens.

Consumer Overview Side Effect

SIDE EFFECTS: Dry mouth, decreased sweating, dizziness, drowsiness, blurred vision, widened pupils, nausea/vomiting, or constipation may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor immediately if any of these unlikely but serious side effects occur: mental/mood changes, eye pain/pressure, fast/pounding heartbeat, difficulty urinating, decreased sexual ability.

A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

 

Read the Cantil (mepenzolate bromide) Side Effects Center for a complete guide to possible side effects

Learn More »
 

PRECAUTIONS: Before taking mepenzolate, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: glaucoma, myasthenia gravis, movement/blockage disorders of the stomach/bowels (e.g., paralytic ileus, pyloroduodenal stenosis, achalasia, intestinal atony), difficulty urinating (e.g., prostatic hypertrophy), a certain bowel disorder (toxic megacolon).

Before using this medication, tell your doctor or pharmacist your medical history, especially of: liver disease, kidney disease, heart/blood vessel disease (e.g., congestive heart failure, coronary artery disease, tachycardia), high blood pressure, overactive thyroid (hyperthyroidism), esophagus problems (e.g., GERD), nerve disorders (e.g., autonomic neuropathy), diarrhea, breathing problems (e.g., asthma), a certain bowel disease (ulcerative colitis).

Before having surgery, tell your doctor or dentist that you are using this medication.

This drug may make you dizzy or drowsy or cause blurred vision. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely. Limit alcoholic beverages.

This medication can decrease sweating. To prevent heatstroke, avoid becoming overheated in hot weather, in saunas, and during exercise/other strenuous activities.

Caution is advised when using this drug in the elderly because they may be more sensitive to the side effects.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is not known whether this drug passes into breast milk. Consult your doctor before breast-feeding.

Consumer Overview Missed Dose

DRUG INTERACTIONS: Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.

This drug should not be used with the following medication because a very serious interaction may occur: pramlintide.

If you are currently using the medication listed above, tell your doctor or pharmacist before starting mepenzolate.

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: antihistamines (e.g., diphenhydramine, meclizine), antispasmodics (e.g., dicyclomine), belladonna alkaloids (e.g., scopolamine, atropine), certain antiarrhythmic drugs (e.g., quinidine, procainamide), certain drugs for Parkinson's disease (e.g., amantadine, levodopa, benztropine, trihexyphenidyl), corticosteroids (e.g., prednisone), digoxin (slow-dissolving type), drugs for glaucoma (e.g., timolol), drugs that affect stomach movement (e.g., metoclopramide), drugs which depend on stomach acidity (e.g., ketoconazole), MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine), nitrates (e.g., isosorbide dinitrate), phenothiazines (e.g., promethazine, chlorpromazine), potassium tablets/capsules, tricyclic antidepressants (e.g., amitriptyline).

Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: anti-seizure drugs (e.g., carbamazepine), medicine for sleep or anxiety (e.g., alprazolam, diazepam, zolpidem), muscle relaxants, narcotic pain relievers (e.g., meperidine, codeine), psychiatric medicines (e.g., chlorpromazine, risperidone, trazodone).

Check the labels on all your medicines (e.g., cough-and-cold products) because they may contain drowsiness-causing ingredients. Ask your pharmacist about using those products safely.

This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

 

OVERDOSE: If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: mental/mood changes, fainting, muscle weakness, fast/irregular heartbeat, hot/dry skin, trouble breathing.

 

NOTES: Do not share this medication with others.

 

MISSED DOSE: If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

 

STORAGE: Store at room temperature below 86 degrees F (30 degrees C) away from light and moisture. Do not store in the bathroom. Keep all medicines away from children and pets.

Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

 

Information last revised March 2013. Copyright(c) 2013 First Databank, Inc.

Patient Detailed Side Effect

Brand Names: Cantil

Generic Name: mepenzolate (Pronunciation: me PEN zoe late)

  • What is mepenzolate (Cantil)?
  • What are the possible side effects of mepenzolate (Cantil)?
  • What is the most important information I should know about mepenzolate (Cantil)?
  • What should I discuss with my healthcare provider before taking mepenzolate (Cantil)?
  • How should I take mepenzolate (Cantil)?
  • What happens if I miss a dose (Cantil)?
  • What happens if I overdose (Cantil)?
  • What should I avoid while taking mepenzolate (Cantil)?
  • What other drugs will affect mepenzolate (Cantil)?
  • Where can I get more information?

What is mepenzolate (Cantil)?

 

Mepenzolate reduces stomach acid and helps control muscle spasms in the intestines.

Mepenzolate is used to treat peptic ulcers of the stomach. Mepenzolate does not help heal an ulcer.

Mepenzolate may also be used for purposes other than those listed in this medication guide.

What are the possible side effects of mepenzolate (Cantil)?

 

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using mepenzolate and call your doctor at once if you have any of these serious side effects:

  • urinating less than usual or not at all;
  • confusion, hallucinations;
  • unusual thoughts or behavior; or
  • fast, pounding, or uneven heartbeats.

Less serious side effects may include:

  • drowsiness, dizziness, headache;
  • blurred vision;
  • memory problems;
  • problems with balance or coordination;
  • nausea, vomiting, constipation, bloating; or
  • decreased sweating.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the Cantil (mepenzolate bromide) Side Effects Center for a complete guide to possible side effects

Learn More »
 

What is the most important information I should know about mepenzolate (Cantil)?

 

You should not take this medication if you are allergic to mepenzolate, or if you have problems with urination, a blockage in your intestines, severe ulcerative colitis, glaucoma, or myasthenia gravis.

Before taking mepenzolate tell your doctor if you have diarrhea, numbness or tingling in your hands or feet, liver or kidney disease, ulcerative colitis, heart disease, high blood pressure, overactive thyroid, hiatal hernia, acid reflux disease, an enlarged prostate, asthma, or any allergies.

Mepenzolate can cause side effects that may impair your vision, thinking, or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

Avoid drinking alcohol. It can increase some of the side effects of mepenzolate.

Avoid becoming overheated or dehydrated during exercise and in hot weather. Mepenzolate can decrease sweating, and you could develop heatstroke more easily.

Stop using mepenzolate and call your doctor at once if you stop urinating, or if you have hallucinations, confusion, unusual thoughts or behavior, or if you have fast, uneven, or pounding heartbeats.

Side Effects Centers
  • Cantil

Patient Detailed How Take

What should I discuss with my healthcare provider before taking mepenzolate (Cantil)?

 

You should not take this medication if you are allergic to mepenzolate, or if you have:

  • problems with urination;
  • a blockage in your intestines, paralytic ileus, severe ulcerative colitis, toxic megacolon;
  • glaucoma; or
  • myasthenia gravis.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely take mepenzolate:

  • diarrhea (especially if you have a colostomy or ileostomy);
  • numbness or tingling in your hands or feet;
  • liver or kidney disease;
  • ulcerative colitis;
  • overactive thyroid;
  • congestive heart failure, a heart rhythm disorder, or coronary artery disease;
  • high blood pressure (hypertension);
  • hiatal hernia or acid reflux disease;
  • an enlarged prostate; or
  • asthma or any allergies.

FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether mepenzolate passes into breast milk or if it could harm a nursing baby. Do not take mepenzolate without telling your doctor if you are breast-feeding a baby.

Older adults may be more likely to have side effects from mepenzolate.

How should I take mepenzolate (Cantil)?

 

Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

Your doctor may occasionally change your dose to make sure you get the best results from this medication.

Mepenzolate is usually taken 4 times each day, with meals and at bedtime. Follow your doctor's instructions.

Take this medicine with a full glass of water.

Taking this medication may slow down your digestion, causing a bloated feeling or other stomach discomfort. Talk with your doctor if you have concerns about this effect.

Store mepenzolate at room temperature away from moisture, heat, and direct light.

Side Effects Centers
  • Cantil

Patient Detailed Avoid Taking

What happens if I miss a dose (Cantil)?

 

Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose.Do not take extra medicine to make up the missed dose.

What happens if I overdose (Cantil)?

 

Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include nausea, vomiting, dry mouth, blurred vision, dizziness, headache, dry and hot skin, trouble swallowing, and muscle weakness or stiffness.

What should I avoid while taking mepenzolate (Cantil)?

 

Mepenzolate can cause side effects that may impair your vision, thinking, or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

Avoid drinking alcohol. It can increase some of the side effects of mepenzolate.

Avoid becoming overheated or dehydrated during exercise and in hot weather. Mepenzolate can decrease sweating, and you could develop heatstroke more easily.

What other drugs will affect mepenzolate (Cantil)?

 

The following drugs can interact with mepenzolate. Tell your doctor if you are using any of these:

  • amantadine (Symmetrel);
  • nitroglycerin;
  • heart rhythm medicines such as quinidine (Quinaglute, Cardioquin, Quinidex);
  • sedatives such as diazepam (Valium) or medicines to treat mental illness such as chlorpromazine (Thorazine) or thioridazine (Mellaril);
  • antidepressants such as amitriptyline (Elavil), imipramine (Janimine, Tofranil), isocarboxazid (Marplan), phenelzine (Nardil), or selegiline (Emsam);
  • medicine to treat Parkinson's disease, such as rasagiline (Azilect) or selegiline (Eldepryl); and
  • cold or allergy medicines containing antihistamines such as Benadryl, Dimetapp, Actifed, Chlor-Trimeton, and others.

This list is not complete and there may be other drugs that can interact with mepenzolate. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Where can I get more information?

 

Your pharmacist can provide more information about mepenzolate.


Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2013 Cerner Multum, Inc. Version: 2.02. Revision date: 12/15/2010.

Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.

Healthwise

Side Effects Centers
  • Cantil

Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI